Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
6.74
+0.10 (1.44%)
Nov 5, 2024, 3:49 PM EST - Market open

Recursion Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
1,8922,1361,4612,895--
Market Cap Growth
39.99%46.15%-49.51%---
Enterprise Value
1,4811,8001,0592,317--
Last Close Price
6.649.867.7117.13--
PE Ratio
--6.25-5.65-11.51--
PS Ratio
30.4947.9236.68284.42--
PB Ratio
3.194.613.015.33--
P/FCF Ratio
-5.88-7.13-12.12-14.59--
P/OCF Ratio
-6.07-7.42-17.50-18.25--
EV/Sales Ratio
29.8440.3826.58227.62--
EV/EBITDA Ratio
-4.84-5.53-4.53-13.29--
EV/EBIT Ratio
-4.46-5.14-4.31-12.68--
EV/FCF Ratio
-5.16-6.01-8.78-11.68--
Debt / Equity Ratio
0.150.110.100.000.050.16
Debt / FCF Ratio
-0.26-0.17-0.420.00-0.24-0.20
Asset Turnover
0.070.070.060.020.02-
Quick Ratio
5.544.245.5111.2711.3510.48
Current Ratio
6.074.705.6811.4611.5311.43
Return on Equity (ROE)
-71.18%-69.12%-46.56%-47.51%-54.57%-
Return on Assets (ROA)
-34.35%-32.29%-23.42%-25.14%-26.44%-
Return on Capital (ROIC)
-41.43%-41.64%-28.43%-28.62%-30.76%-
Earnings Yield
-20.10%-15.36%-16.39%-6.44%--
FCF Yield
-18.34%-14.03%-8.25%-6.85%--
Buyback Yield / Dilution
-20.41%-18.41%-40.04%-475.48%-0.98%-
Total Shareholder Return
-20.41%-18.41%-40.04%-475.48%-0.98%-
Source: S&P Capital IQ. Standard template. Financial Sources.